Skip to content

Effects of Combined Rectus Sheath and Ilioinguinal Nerve Block on Opioid Consumption in HALDN

Effects of Combined Rectus Sheath and Ilioinguinal Nerve Block on Opioid Consumption in Hand-Assisted Laparoscopic Donor Nephrectomy Patients: A Randomized Controlled Double-Blind Prospective Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06941259
Enrollment
66
Registered
2025-04-23
Start date
2025-03-30
Completion date
2025-07-28
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional Anesthesia Morbidity

Keywords

rectus sheath block, ilioinguinal nerve block, hand assisted donor nephrectomy

Brief summary

The goal of this double-blind randomized control clinical trial is to investigate the effectiveness of regional anaesthesia blocks (rectus sheath block and ilioinguinal nerve block) on pain management in patients undergoing hand assisted laparoscopic donor nephrectomy surgery. The main question it aims to answer is: Does combined rectus sheath block and ilioinguinal nerve block lower the amount of postoperative opioid consumption? Does reduced postoperative opioid consumption reduce the incidence of potential opioid related side effects? Does the application of nerve block affect length of hospital stay? Researchers will compare patients who had nerve blocks with regional anaesthesia to a placebo group to see if total postoperative opioid consumption. Participants will be randomly divided in two. Regional anaesthesia with local anaesthesia or a placebo will be performed. Patients will be followed 24 hours postoperatively to measure total opioid consumption. Possible side effects, complications and length of hospital stay will be noted.

Detailed description

In this study, it was planned to provide pain management after HALDN by applying a combined rectus sheath block and ilioinguinal nerve block. It is aimed to demonstrate the postoperative analgesic effectiveness of combined rectus sheath and ilioinguinal nerve block applied in addition to general anaesthesia in HALDN surgery. It was aimed to examine the amount of narcotic analgesic consumption in patients who received local anaesthetic for the first 24 hours after surgery. Regional anaesthesia applications with physiological saline, defined as 'Sham Block' in the literature, were preferred as the comparison group. This method is a widely used comparison method and is used to obtain a double-blind study design.

Interventions

PROCEDURERectus sheath and ilioinguinal nerve block with physiological saline

Rectus sheath and ilioinguinal nerve block without local anaesthesia

PROCEDURERectus sheath and ilioinguinal nerve block with local anaesthesia

Rectus sheath and ilioinguinal nerve block with local anaesthesia

Sponsors

Koç University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Masking description

The patient will be blind whether they receive local anaesthesia or physiological saline as the nerve block ingredient. The care providers will be blind to the solution when they are performing the regional anaesthesia. The care providers will be blind when they are monitoring the patient after surgery.

Intervention model description

Group A: After patients anesthetized under general anaesthesia, a combined rectus sheath block and ilioinguinal nerve block will be applied with physiological saline. Group B: After patients anesthetized under general anaesthesia, a combined rectus sheath block and ilioinguinal nerve block will be applied with 0.25% bupivacaine.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* The donors reviewed by the transplant committee and deemed suitable for nephrectomy. * Laparoscopic hand assisted donor nephrectomy operation is planned.

Exclusion criteria

* Allergy to any of the drugs to be used in treatment * Patients using chronic narcotics or narcotic receptor agonists * Patients with psychiatric disorders * Patients with chronic organ failure * Patients without end organ damage * The patients who did not give consent * Foreign national patients * Patients with American Society of Anaesthesiologists (ASA) physical status classification score III and above

Design outcomes

Primary

MeasureTime frameDescription
Primary Outcome24 hours post-surgeryDetermination of the total amount of narcotic painkillers used during this period.

Secondary

MeasureTime frameDescription
Secondary Outcome24 hours post-surgeryNumeric rating scale scores for pain after surgery. Numeric rating scale scores for pain of 1 being minimum amount of pain and 10 being the worse pain.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026